1 |
De Fabritiis S, Valentinuzzi S, Piras G, Cicalini I, Pieragostino D, Pagotto S, Perconti S, Zucchelli M, Schena A, Taschin E, Berteşteanu GS, Esposito DL, Stigliano A, De Laurenzi V, Schiavi F, Sanna M, Del Boccio P, Verginelli F, Mariani-Costantini R. Targeted metabolomics detects a putatively diagnostic signature in plasma and dried blood spots from head and neck paraganglioma patients. Oncogenesis 2023;12:10. [PMID: 36841802 DOI: 10.1038/s41389-023-00456-4] [Reference Citation Analysis]
|
2 |
Javaid S, Patton A, Tinoco G, Oghumu S, Iwenofu OH. Metastatic sporadic paraganglioma with EWSR1::CREM gene fusion: A unique molecular profile that expands the phenotypic diversity of the molecular landscape of the EWSR1::CREM gene fusion positive tumors. Genes Chromosomes Cancer 2023;62:85-92. [PMID: 36083250 DOI: 10.1002/gcc.23094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Li M, Prodanov T, Meuter L, Kerstens MN, Bechmann N, Prejbisz A, Remde H, Timmers HJLM, Nölting S, Talvacchio S, Berends AMA, Fliedner S, Robledo M, Lenders JWM, Pacak K, Eisenhofer G, Pamporaki C. Recurrent Disease in Patients With Sporadic Pheochromocytoma and Paraganglioma. J Clin Endocrinol Metab 2023;108:397-404. [PMID: 36190922 DOI: 10.1210/clinem/dgac563] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|